Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $405.4 which represents a decrease of $-5.84 or -1.42% from the prior close of $411.24. The stock opened at $410.18 and touched a low ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...